Lipid Luminations

Lipid Luminations

By ReachMDMedicine
Download on the App Store

Lipid Luminations episodes

  • Impacting Atherosclerosis
    Host: Larry Kaskel, MD
    Guest: Kevin Williams, MD

    Host Dr. Larry Kaskel welcomes Dr. Kevin J. Williams, professor of medicine and professor of biochemistry and molecular biology in the division of endocrinology at Thomas Jefferson University , to discuss rapid regression and stabilization of athlerosclerosis. How can this be achieved pharmacologically, even in patients with advanced plaques? Dr. Williams also highlights effective measures to improve plasma lipoprotein profiles.

    Brought to you by:

    13 min
  • The COURAGE Trial's Impact on Clinical Practice
    Host: Larry Kaskel, MD
    Guest: Perry Weinstock, MD

    Host Dr. Larry Kaskel welcomes Dr. Perry Weinstock, director of clinical cardiology at Cooper University Hospital and associate professor of medicine at the UMDNJ-Robert Wood Johnson Medical School, to evaluate the clinical implications of the COURAGE Trial, in part, through a review of its optimal medical therapies. In the context of this trial, how can we work with our patients to truly optimize medical therapy?

    Brought to you by:

    13 min
  • CVD Risk Factors and Cognitive Impairment
    Host: Larry Kaskel, MD
    Guest: David T. Nash, MD

    Dr. Larry Kaskel welcomes Dr. David T. Nash to Lipid Luminations. Dr. Nash is with Syracuse Preventive Cardiology and will discuss how lipid abnormalities and genetic markers are associated with an increased risk for cardiovascular disease and cognitive impairment. He will also speak about how patients with hypertension who are treated experience fewer cardiovascular disease events as well as less cognitive impairment than similar untreated patients.

    Brought to you by:

    13 min
  • Emerging Biomarkers and New Drugs
    Host: Larry Kaskel, MD
    Guest: Michael H. Davidson, MD

    Host Dr. Larry Kaskel welcomes Dr. Michael Davidson, Director of Preventive Cardiology at the University of Chicago School of Medicine and Executive Medical Director of Radiant Research in Chicago. Dr. Davidson will discuss C-reactive protein (CRP) levels and other emerging biomarkers as well as new drugs on the horizon.

    Brought to you by:

    13 min
  • Misconceptions in Coronary Risk & Lipid Medicine
    Host: Larry Kaskel, MD
    Guest: James Ehrlich, MD

    Host Dr. Larry Kaskel is joined by Dr. James Ehrlich, chief medical officer of Atherotech, the Birmingham-based company that has developed the VAP lipid test, and clinical associate professor of endocrinology at University of Colorado School of Medicine. They will discuss common misconceptions in such areas as: the value of standard cholesterol tests, HDL and LDL numbers, particle numbers as a good predictor of risk, and coronary calcium.

    Brought to you by:

    13 min
  • Advanced Coronary Risk Assessment Insights
    Host: Larry Kaskel, MD
    Guest: James Ehrlich, MD

    Dr. Larry Kaskel welcomes Dr. James Ehrlich, chief medical officer of Atherotech and clinical associate professor in the endocrinology division of the University of Colorado School of Medicine, who has developed advanced coronary risk assessment programs in four U.S. cities. Dr. Ehrlich will describe evidence suggesting that office-based risk assessment (Framingham) fails to identify high risk individuals. He will detail which patients need advanced lipid testing as well as discuss tools and emerging biomarkers that are of highest value.

    Brought to you by:

    13 min
  • CVD Risk Prediction
    Host: Larry Kaskel, MD
    Guest: Donald Lloyd-Jones, MD

    Dr. Larry Kaskel is joined by Dr. Donald Lloyd-Jones, Associate Professor of Preventive Medicine at Northwestern University and a practicing preventive cardiologist at Northwestern Memorial Hospital. They will discuss the current state of the art as well as improvements on CVD risk prediction. They will also discuss what lifetime risk estimates tell us and how to achieve low lifetime risk.

    Brought to you by:

    13 min
  • Atherosclerosis Imaging
    Host: Larry Kaskel, MD
    Guest: Paolo Raggi, MD

    Dr. Larry Kaskel welcomes Dr. Paolo Raggi to Lipid Luminations. Dr. Raggi is Professor of Medicine-Cardiology and Professor of Radiology at Emory Universtiy. The discussion will focus on whether risk assessment may be improved by additional tests such as coronary artery calcium scoring (CACS). Can a change in calcium score be used to assess the efficacy of lipid therapy?

    Brought to you by:

    13 min
  • Managing Statin Intolerant Patients
    Host: Larry Kaskel, MD
    Guest: Peter Jones, MD

    Dr. Larry Kaskel welcomes Dr. Peter Jones to Lipid Luminations. Dr. Jones is Associate Professor in the Center for Cardiovascular Disease Prevention of the Methodist DeBakey Heart Center and Baylor College of Medicine in Houston. They will discuss how common statin intolerance is and what other drug options exist to lower LDL-C. They will further explore the side effects of these other options and whether or not they reduce CHD risk.

    Brought to you by:

    13 min
  • The ENHANCE Study
    Host: Larry Kaskel, MD
    Guest: Jerome D. Cohen, MD

    Dr. Kaskel welcomes Dr. Jerome Cohen to Lipid Luminations. Dr. Cohen is a cardiologist and professor of medicine and cardiology at St. Louis University where he also serves as the director of preventive cardiology. They will be delving into the controversial issues of The Enhance Study plus discussing what doctors should be recommending in the wake of the results.

    Brought to you by:

    13 min

About Lipid Luminations

From the publisher's feed

Get to the heart of the most recent advances in lipid management and cardiovascular disease with Lipid Luminations, which features scientific and clinical research updates, novel…